TickerFactsScreenerDevelopers

CRESCENT BIOPHARMA, INC. (CBIO) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $2.38M2014: $6.46M2015: $7.99M2016: $7.09M2017: $8.88M2018: $9.37M2019: $13.77M2020: $14.61M2021: $12.74M2022: $8.88M2023: $6.90M2024: $47.10M2025: $37.28M$37.28M
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$37.28M-20.8%
2024$47.10M+582.3%
2023$6.90M-22.3%
2022$8.88M-30.3%
2021$12.74M-12.8%
2020$14.61M+6.1%
2019$13.77M+46.9%
2018$9.37M+5.6%
2017$8.88M+25.3%
2016$7.09M-11.3%
2015$7.99M+23.7%
2014$6.46M+171.9%
2013$2.38M—